A Robust Screen for Inhibitors and Enhancers of Phosphoinositide-3 Kinase (PI3K) Activities by Ratiometric Fluorescence Superquenching

Abstract

Aberrant regulation of phosphoinositide 3-kinase (PI3K) activity is implicated in various diseases such as cancer and diabetes. Thus, high-throughput screening (HTS) of small-molecule inhibitors for PI3 kinases is an appealing strategy for drug development. Despite the attractiveness of lipid kinases as drug targets, screening for inhibitors for PI3K activities has been hampered by limited assay formats adaptable for HTS. The authors describe a homogeneous, direct, and nonradioactive assay for highly sensitive detection of PI3Kα, β, δ, and γ activities, which is suitable for HTS. The assay is based on fluorescence superquenching of a conjugated polymer upon metal-ion-mediated association of phosphorylated and dye-labeled substrates. As a result of phosphorylation, quencher and polymer are brought into proximity, and fluorescent energy transfer occurs. This event can be monitored as either fluorescence quench of the polymer or as enhanced emission from the quencher. Ratiometric analysis of the wavelengths eliminates interferences from autofluorescing compounds, which are present in HTS libraries. The platform has been adapted for the 384-well microplate format and delivers Z factors of > 0.6 at substrate conversions as low as 7%. Using this assay platform, several unreported inhibitors and activators of PI3Ks were identified in an 84- compound screen.

Keywords

cancer diabetes phosphoinositide-3 kinases high-throughput screening superquenching

References

Cohen P : The origins of protein phosphorylation. Nat Cell Biol 2002;4:127-130.

Vanhaesebroeck B , Waterfield MD : Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 1999;1:239-254.

Fuchikami K , Togame H , Sagara A , Satoh T , Gantner F , Bacon KB , et al : A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3- kinase gamma. J Biomol Screen 2002;7:441-450.

Drees BE , Weipert A , Hudson H , Ferguson CG , Chakravarty L , Prestwich GD : Competitive fluorescence polarization assays for the detection of phosphoinositide kinase and phosphatase activity. Comb Chem High Throughput Screen 2003;6:321-330.

Rodems SM , Hamman BD , Lin C , Zhao J , Shah S , Heidary D , et al : A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases. Assay Drug Dev Technol 2002;1:9-19.

Gray A , Olsson H , Batty IH , Priganica L , Downes R : Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts Anal Biochem 2003;313:234-245.

Rininsland F , Xia W , Wittenburg S , Shi X , Stankewicz C , Achyuthan K , et al : Metal ion-mediated polymer superquenching for highly sensitive detection of kinase and phosphatase activities. Proc Natl Acad Sci USA 2004;101:15295-15300.

Chen L , McBranch DW , Wang HL , Helgeson R , Wudl F , Whitten DG : Highly sensitive biological and chemical sensors based on reversible fluorescence quenching in a conjugated polymer. Proc Natl Acad Sci USA 1999;96:12287-12289.

Rininsland F , Stankewicz C , Weatherford W , McBranch DW : High-throughput kinase assays with protein substrates using fluorescent polymer superquenching. BMC Biotechnol 2005;5:16-16.

10.

Kushon S , Bradford K , Marin V , Suhrada C , Armitage BA , McBranch DW , et al : Detection of single nucleotide mismatches via fluorescent polymer superquenching. Langmuir 2003;19:6456-6464.

11.

Vedvik KL , Eliason HC , Hoffman RL , Gibson JR , Kupcho KR , Somberg RL , et al : Overcoming compound interference in fluorescence polarization-based kinase assays usingfar-redtracers. Assay Drug Dev Technol 2004;2:193-203.

12.

Zhang JH , Chung TD , Oldenburg KR : A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1993;4:67-73.

13.

Powis G , Bonjouklian R , Berggren MM , Gallegos A , Abraham R , Ashendel C , et al : Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res 1994;54:2419-2423.

14.

Vlahos CJ , Matter WF , Hui KY , Brown RF : A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). J Biol Chem 1994;269:5241-5248.

15.

Matter WF , Brown RF , Vlahos CJ : The inhibition of phosphatidylinositol 3- kinase by quercetin and analogs. Biochem Biophys Res Commun 1992;185:624-631.